These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis. Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377 [TBL] [Abstract][Full Text] [Related]
3. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer. Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968 [TBL] [Abstract][Full Text] [Related]
4. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688 [TBL] [Abstract][Full Text] [Related]
5. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer. Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264 [TBL] [Abstract][Full Text] [Related]
6. [Cost of colorectal cancer in France in 1999]. Selke B; Durand I; Marissal JP; Chevalier D; Lebrun T Gastroenterol Clin Biol; 2003 Jan; 27(1):22-7. PubMed ID: 12594362 [TBL] [Abstract][Full Text] [Related]
7. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region]. Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006 [TBL] [Abstract][Full Text] [Related]
8. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany. Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412 [TBL] [Abstract][Full Text] [Related]
9. Health care costs for treatment of disseminated breast cancer. Dahlberg L; Lundkvist J; Lindman H Eur J Cancer; 2009 Jul; 45(11):1987-91. PubMed ID: 19398326 [TBL] [Abstract][Full Text] [Related]
10. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma]. Luo SK; Li J; Hong WD; Zhao Y; Tong XZ Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805 [TBL] [Abstract][Full Text] [Related]
11. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim. Annemans L; Van Overbeke N; Standaert B; Van Belle S J Nurs Manag; 2005 May; 13(3):265-74. PubMed ID: 15819840 [TBL] [Abstract][Full Text] [Related]
12. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial. Rifkin RM; Gregory SA; Mohrbacher A; Hussein MA Cancer; 2006 Feb; 106(4):848-58. PubMed ID: 16404741 [TBL] [Abstract][Full Text] [Related]
13. [Compared medical costs of treating ovarian cancer patients with weekly paclitaxel, carboplatin (TC) chemotherapy]. Nomura H; Nagai S; Shinohara T; Iwashita M; Yajima M; Takatoya S Gan To Kagaku Ryoho; 2007 Jul; 34(7):1091-4. PubMed ID: 17637546 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Bennett CL; Calhoun EA Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690 [TBL] [Abstract][Full Text] [Related]
15. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224 [TBL] [Abstract][Full Text] [Related]
16. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands. Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601 [TBL] [Abstract][Full Text] [Related]
17. [Comparative cost analysis of outpatient and inpatient rehabilitation for cardiac diseases]. Zeidler J; Mittendorf T; Vahldiek G; von der Schulenburg JM Herz; 2008 Sep; 33(6):440-7. PubMed ID: 19156379 [TBL] [Abstract][Full Text] [Related]
18. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results. Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258 [TBL] [Abstract][Full Text] [Related]
19. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients. Dadacaridou M; Papanicolaou X; Maltesas D; Megalakaki C; Patos P; Panteli K; Repousis P; Mitsouli-Mentzikof C J BUON; 2007; 12(1):41-4. PubMed ID: 17436400 [TBL] [Abstract][Full Text] [Related]
20. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]